The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing.

Saved in:
Bibliographic Details
Title: The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing.
Authors: Morandi F; UOSD Laboratory of Cell Therapies, IRCCS Istituto Giannina Gaslini, Genova, Italy., Della Lastra M; UOSD Laboratory of Cell Therapies, IRCCS Istituto Giannina Gaslini, Genova, Italy., Pastorino F; UOSD Laboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Genova, Italy., Ciampi E; UOSD Laboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Genova, Italy., Faraci M; Hematopoietic Stem Cell Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy., Brignole C; UOSD Laboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Genova, Italy., Giardino S; Hematopoietic Stem Cell Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy., Airoldi I; UOSD Laboratory of Cell Therapies, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Source: Frontiers in immunology [Front Immunol] 2026 Jan 30; Vol. 17, pp. 1755500. Date of Electronic Publication: 2026 Jan 30 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1755500